Kun‐Tu Yeh

4.7k total citations
151 papers, 3.7k citations indexed

About

Kun‐Tu Yeh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kun‐Tu Yeh has authored 151 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 34 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Kun‐Tu Yeh's work include Cancer-related gene regulation (22 papers), Epigenetics and DNA Methylation (15 papers) and RNA modifications and cancer (14 papers). Kun‐Tu Yeh is often cited by papers focused on Cancer-related gene regulation (22 papers), Epigenetics and DNA Methylation (15 papers) and RNA modifications and cancer (14 papers). Kun‐Tu Yeh collaborates with scholars based in Taiwan, United States and Singapore. Kun‐Tu Yeh's co-authors include Jan‐Gowth Chang, Ya‐Sian Chang, Ming‐Feng Hou, Shou‐Jen Kuo, Shou‐Tung Chen, Kong‐Bung Choo, Yueh‐Min Lin, Jui‐Chang Chen, Shu‐Hui Lin and Ming‐Yu Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLANT PHYSIOLOGY.

In The Last Decade

Kun‐Tu Yeh

149 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kun‐Tu Yeh Taiwan	35	2.0k	783	751	689	398	151	3.7k
S Sułkowski Poland	28	1.4k 0.7×	575 0.7×	655 0.9×	355 0.5×	300 0.8×	204	2.9k
Vittorio Colantuoni Italy	42	2.8k 1.4×	881 1.1×	736 1.0×	144 0.2×	480 1.2×	124	4.6k
Brian J. Altman United States	23	3.0k 1.5×	700 0.9×	2.2k 2.9×	294 0.4×	412 1.0×	44	4.6k
Uwe Knippschild Germany	40	3.5k 1.8×	1.5k 1.9×	714 1.0×	183 0.3×	874 2.2×	134	6.0k
Jaime Font de Mora Spain	29	1.7k 0.9×	581 0.7×	462 0.6×	148 0.2×	340 0.9×	94	3.1k
Hidehito Kotani Japan	25	1.9k 1.0×	779 1.0×	301 0.4×	195 0.3×	562 1.4×	42	3.4k
Hong Yin China	32	1.8k 0.9×	531 0.7×	880 1.2×	147 0.2×	193 0.5×	90	3.6k
Ho Lee South Korea	33	2.8k 1.4×	582 0.7×	664 0.9×	111 0.2×	258 0.6×	157	4.1k
Carlos Sebastián United States	21	1.6k 0.8×	584 0.7×	520 0.7×	170 0.2×	735 1.8×	35	3.3k
Hui Hua China	24	1.8k 0.9×	562 0.7×	501 0.7×	93 0.1×	173 0.4×	63	3.0k

Countries citing papers authored by Kun‐Tu Yeh

Since Specialization

Citations

This map shows the geographic impact of Kun‐Tu Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Tu Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Tu Yeh more than expected).

Fields of papers citing papers by Kun‐Tu Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Tu Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Tu Yeh. The network helps show where Kun‐Tu Yeh may publish in the future.

Co-authorship network of co-authors of Kun‐Tu Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Tu Yeh. A scholar is included among the top collaborators of Kun‐Tu Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Tu Yeh. Kun‐Tu Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeh, Chung‐Min, et al.. (2025). Comprehensive bioinformatic analysis reveals prognostic significance and functional insights of candidate gene expression in colorectal cancer. Scientific Reports. 15(1). 5659–5659.

Wu, Pei‐Ru, et al.. (2023). Biological and clinical significance of the AGE-RAGE axis in the aggressiveness and prognosis of prostate cancer. Journal of Food and Drug Analysis. 31(4). 664–682. 3 indexed citations

Yeh, Kun‐Tu, Yu‐Ming Chuang, Yu‐Ting Lee, et al.. (2021). Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers. PLoS ONE. 16(4). e0250499–e0250499. 4 indexed citations

Chung, Chia‐Min, et al.. (2021). Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment. Journal of Personalized Medicine. 11(7). 591–591. 7 indexed citations

Nithiyanantham, Srinivasan, Hui‐Ting Hsu, Chia‐Min Chung, et al.. (2021). Arecoline N-oxide initiates oral carcinogenesis and arecoline N-oxide mercapturic acid attenuates the cancer risk. Life Sciences. 271. 119156–119156. 16 indexed citations

Lin, Ching‐Hsiung, Sheng‐Hao Lin, Kun‐Tu Yeh, et al.. (2020). Association between EGFR Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer. Diagnostics. 10(9). 692–692. 7 indexed citations

Chang, Chun‐Chi, Wen‐Wei Sung, Hui‐Ting Hsu, et al.. (2018). Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study. BMJ Open. 8(6). e021385–e021385. 10 indexed citations

Cheng, Jing‐Yan, Sheng‐Hung Wang, Yi-Chien Tsai, et al.. (2014). Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis. Cancer Research. 74(23). 6856–6866. 49 indexed citations

Hung, Shih‐Ya, et al.. (2014). Histone-modifying genes as biomarkers in hepatocellular carcinoma.. PubMed. 7(5). 2496–507. 40 indexed citations

10.

Lin, Yi‐Ching, Tze‐Kiong Er, Kun‐Tu Yeh, Chih‐Hsing Hung, & Jan‐Gowth Chang. (2014). Rapid Identification of FGFR2 Gene Mutations in Taiwanese Patients With Endometrial Cancer Using High-resolution Melting Analysis. Applied immunohistochemistry & molecular morphology. 23(7). 532–537. 3 indexed citations

11.

Chu, Pei‐Yi, Chung‐Min Yeh, Kun‐Tu Yeh, & Liu Ch. (2012). Tubulopapillary Carcinoma-A Frequent Over-Diagnosed Entity in Canine Mammary Gland Tumors. 38(2). 67–74.

12.

Peng, Chih‐Yu, Hui‐Wen Yang, Yu‐Chao Chang, et al.. (2012). Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway. Evidence-based Complementary and Alternative Medicine. 2012. 1–10. 40 indexed citations

13.

Hou, Pei‐Chi, Kuan‐Der Lee, Pei‐Yi Chu, et al.. (2011). Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells. Cancer Research. 71(13). 4653–4663. 79 indexed citations

14.

Yang, Yu‐Shih, Gwo‐Chin Ma, Jin‐Chung Shih, et al.. (2011). Experimental treatment of bilateral fetal chylothorax using in‐utero pleurodesis. Ultrasound in Obstetrics and Gynecology. 39(1). 56–62. 26 indexed citations

15.

Chang, Chia‐Chu, et al.. (2010). Non-Diabetic Renal Diseases in Type 2 Diabetic Patients with Renal Involvement: Clinicopathological Study in a Single Medical Center in Taiwan. 24(3). 157–166. 2 indexed citations

16.

Li, Chien-Te, et al.. (2010). The mechanisms of action of Tianhua^™on antitumor activity in lung cancer cells. Pharmaceutical Biology. 48(11). 1302–1309. 20 indexed citations

17.

Liu, Jinglan, et al.. (2010). Borderline clear cell adenofibroma with extensive hemorrhagic necrosis. Hematology/Oncology and Stem Cell Therapy. 3(3). 158–160. 5 indexed citations

18.

Hsu, Yung-Hsiang, et al.. (2008). Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.. PubMed. 22(4). 457–62. 7 indexed citations

19.

Lin, Torng‐Sen, Ta-Cheng Chen, Ching‐Yuan Cheng, et al.. (2003). Right Side Approach for Video-Assisted Thoracoscopic Thymectomy in Treating Myasthenia Gravis. 8(3). 149–154. 1 indexed citations

20.

Yeh, Kun‐Tu, et al.. (2001). Mutation Analysis of RAS Oncogenes in Oral Squamous Cell Carcinoma. 6(2). 69–73. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact